Tumor‐associated macrophages in liver cancer: From mechanisms to therapy

Tumor‐associated macrophages in liver cancer: From mechanisms to therapy

Abstract Multidimensional analyses have demonstrated the presence of a unique tumor microenvironment (TME) in liver cancer. Tumor‐associated macrophages (TAMs) are among the most abundant immune cells infiltrating the TME and are present at all stages of liver cancer progression, and targeting TAMs...

Full description

Bibliographic Details
Main Authors:	Kun Cheng, Ning Cai, Jinghan Zhu, Xing Yang, Huifang Liang, Wanguang Zhang
Format:	Article
Language:	English
Published:	Wiley 2022-11-01
Series:	Cancer Communications
Subjects:	hepatocellular carcinoma intrahepatic cholangiocarcinoma tumor‐associated macrophages immunotherapy
Online Access:	https://doi.org/10.1002/cac2.12345

Similar Items

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
by: Pil Soo Sung
Published: (2022-07-01)

Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy
by: Yinqi Zhang, et al.
Published: (2024-08-01)

Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk
by: Wen-juan Tong, et al.
Published: (2022-10-01)

ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway
by: Jialu Chen, et al.
Published: (2023-12-01)

CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
by: Dalong Sun, et al.
Published: (2020-01-01)

Radiogenomics and Radiomics in Liver Cancers
by: Aman Saini, et al.
Published: (2018-12-01)

The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
by: Marlene Sophia Kohlhepp, et al.
Published: (2023-02-01)

Nomograms predict survival outcome of Klatskin tumors patients
by: Feng Qi, et al.
Published: (2020-02-01)

Macrophages and hepatocellular carcinoma
by: Zhiqiang Tian, et al.
Published: (2019-09-01)

Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
by: Hsin-Lun Lee, et al.
Published: (2023-07-01)

The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value
by: Lavinia Patricia Mocan, et al.
Published: (2023-04-01)

Expression of Fascin-1 and its diagnostic value in liver cancer
by: Shi-Ping Lu, et al.
Published: (2024-05-01)

A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
by: Mengmeng Wang, et al.
Published: (2018-03-01)

Indications and outcomes of liver transplantation for liver tumors in the United States
by: Kenji Okumura, et al.
Published: (2024-06-01)

Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma
by: Zhao-Ru Dong, et al.
Published: (2024-09-01)

Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
by: Dexi Zhou, et al.
Published: (2021-07-01)

PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
by: Fuqiang Huang, et al.
Published: (2024-03-01)

Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study
by: Lintao Chen, et al.
Published: (2023-03-01)

CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming
by: Shiqi Liu, et al.
Published: (2024-06-01)

Thermal ablation enhances immunotherapeutic effect of IP-001 on orthotopic liver cancer in a rat model
by: Yan Li, et al.
Published: (2024-12-01)

N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2
by: Teng Cai, et al.
Published: (2024-09-01)

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine
by: Riccardo Carloni, et al.
Published: (2022-11-01)

Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway
by: Minghao Xu, et al.
Published: (2022-08-01)

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy
by: Meng-Qi Liu, et al.
Published: (2023-12-01)

Head-to-head study of [18F]FAPI-04 PET/CT and [18F]FDG PET/CT for non-invasive assessment of liver cancer and its immunohistochemical markers
by: Zhiying Liang, et al.
Published: (2024-11-01)

RETRACTED: Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis
by: Liqing Zhang, et al.
Published: (2024-01-01)

Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma
by: Han Liu, et al.
Published: (2024-08-01)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
by: Oraianthi Fiste, et al.
Published: (2021-04-01)

Precision N‐glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma
by: Jun Li, et al.
Published: (2022-06-01)

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
by: Xiu-Tao Fu, et al.
Published: (2019-03-01)

Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma
by: Chen Y, et al.
Published: (2023-10-01)

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
by: Xinai Liu, et al.
Published: (2022-07-01)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
by: Linping Xu, et al.
Published: (2022-09-01)

The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
by: Xinyi Zhang, et al.
Published: (2023-12-01)

Percutaneous Radio-frequency Assisted Liver Partition with Portal vein embolization in Staged liver resection (PRALPPS) in patients with perihilar and intrahepatic cholangiocarcinoma: evaluation of short-term results
by: O. V. Melekhina, et al.
Published: (2019-04-01)

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
by: Zijuan Zou, et al.
Published: (2023-02-01)

Differentially expressed non-coding RNAs and their regulatory networks in liver cancer
by: Nurbubu T. Moldogazieva, et al.
Published: (2023-09-01)

Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective study
by: Sihui Zhu, et al.
Published: (2024-10-01)

Conversion therapy of intrahepatic cholangiocarcinoma
by: Wang Zhiwei, et al.
Published: (2020-12-01)

Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress
by: Ziwei Li, et al.
Published: (2024-06-01)